Healthcare ❯ Pharmaceuticals ❯ Clinical Trials

Product Development

Market Research

Verrica Reports $5 Million Q1 Revenue as Wycanth Grows and Phase 3 Wart Program Advances

Cash on hand covers operations into early 2027.